共 58 条
[1]
Chow W-H(2010)Epidemiology and risk factors for kidney cancer Nat Reviews Urol 7 245-57
[2]
Dong LM(2021)Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response Proc Natl Acad Sci 118 e2103240118-35
[3]
Devesa SS(1995)Adult renal epithelial neoplasms Am J Clin Pathol 103 624-69
[4]
Zhang Y(2020)SEOM clinical guideline for treatment of kidney cancer (2019) Clin Transl Oncol 22 256-54
[5]
Weiss LM(2020)Epidemiology of renal cell carcinoma World J Oncol 11 79-94
[6]
Gelb AB(2008)Seven years after laparoscopic radical nephrectomy: oncologic and renal functional outcomes Urology 71 1149-9
[7]
Jeffrey L(2021)Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma N Engl J Med 385 683-44
[8]
Medeiros M(2016)Association of pembrolizumab with tumor response and survival among patients with advanced melanoma JAMA 315 1600-3
[9]
Lázaro SA(2021)Tuberculosis following programmed cell death receptor-1 (PD-1) inhibitor in a patient with non-small cell lung cancer. Case report and literature review Cancer Immunol Immunother 70 935-11
[10]
Padala JR(2020)Diagnosis and management of hematological adverse events induced by immune checkpoint inhibitors: a systematic review Front Immunol 11 1354-6